About the Supplier
Certifications
-
ISO 13485
Description
Bioabsorbable Evolvemer™ TCP30PLGA is a biocompatible composite of bioabsorbable 85L/15G PLGA base polymer and beta-tri-calcium phosphate (β-TCP).
The β-TCP particle size distribution is optimized in this high-quality composite. This makes its processing easier and improves the mechanical properties of the final products.
Biocompatibility of the Evolvemer™ Composite has been evaluated according to ISO 10993-1:2009 (“Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”). Based on the evaluation, Evolvemer™ Composite presents no risk of systemic toxicological effects.
Cytotoxicity and Plastic Class V tests have been conducted for Evolvemer™ Composite to support the biocompatibility statement of the composite. However, it is the sole responsibility of the manufacturer of the final end-use product to determine the biocompatibility of the final product.
Specifications
| Brand | arctic biomaterials, evolvemer™ |
| Applications | orthopedics, sports medicine, veterinary, dental |
| Materials | plga + β-tcp |
| Chemical-based composition | - not specified - |
| Density | - not specified - |
| Porosity | - not specified - |
| Processing methods | - not specified - |
| Biodegradability | - not specified - |
| Resorbability | - not specified - |
| Reinforcement | - not specified - |
Similar products
Arctic Biomaterials (ABM) specializes in ultra-high strength, bioresorbable materials featuring its...
Evolvecomp™ next-generation bioabsorbable composites are engineered with ABM’s X3 bioactive natural...